Epithelial expression of FHL2 is negatively associated with metastasis-free and overall survival in colorectal cancer

FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo

(2013) Julia Brun et al.   PLoS One

Clinical Importance and Potential Use of Small Molecule Inhibitors of Focal Adhesion Kinase

(2012) Alexander Schultze et al.   Anti-Cancer Agents in Medicinal Chemistry

Overexpression of four and a half LIM domains protein 2 promotes epithelial-mesenchymal transition-like phenotype in fish pre-osteoblasts

(2012) Marta S. Rafael et al.   BIOCHIMIE

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Four-and-a-Half LIM Domain Proteins Inhibit Transactivation by Hypoxia-inducible Factor 1

(2012) Maimon E. Hubbi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Four and a Half LIM-only Protein 2 (FHL2) Activates Transforming Growth Factor β (TGF-β) Signaling by Regulating Ubiquitination of the E3 Ligase Arkadia

(2012) Tian Xia et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The LIM Domain Protein FHL2 Interacts with the NR5A Family of Nuclear Receptors and CREB to Activate the Inhibin-α Subunit Gene in Ovarian Granulosa Cells

(2012) Christina K. Matulis et al.   MOLECULAR ENDOCRINOLOGY

FHL2 Protein Is a Novel Co-repressor of Nuclear Receptor Nur77

(2011) Kondababu Kurakula et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

FHL2 expression in peritumoural fibroblasts correlates with lymphatic metastasis in sporadic but not in HNPCC-associated colon cancer

(2011) Lucia Gullotti et al.   LABORATORY INVESTIGATION

Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer

(2010) W. Zhang et al.   CARCINOGENESIS

Four and a half LIM protein 2 (FHL2) negatively regulates the transcription of E-cadherin through interaction with Snail1

(2010) Wenjing Zhang et al.   EUROPEAN JOURNAL OF CANCER

Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancer

(2010) Kimberly E. Resnick et al.   GYNECOLOGIC ONCOLOGY

Epithelial-mesenchymal transition in cancer development and its clinical significance

(2009) Masaaki Iwatsuki et al.   CANCER SCIENCE

Functional gene silencing mediated by chitosan/siRNA nanocomplexes

(2009) A M Ji et al.   NANOTECHNOLOGY

FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cells

(2009) W. Han et al.   NUCLEIC ACIDS RESEARCH

Requirements for the valid quantification of immunostains on tissue microarray materials using image analysis

(2009) Christine Decaestecker et al.   PROTEOMICS

The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities

(2008) Ming Li et al.   GLIA

Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front

(2008) Olivier Wever et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Mechanisms of Disease: epithelial–mesenchymal transition—does cellular plasticity fuel neoplastic progression?

(2008) Eva A Turley et al.   Nature clinical practice. Oncology